Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 697 posts found.

roche

Roche signs deal with Skyhawk over molecules that modulate RNA splicing

July 17, 2019
Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing

Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …

News
genentech_web

Genentech signs $1 billion deal with Sosei over GCPRs

July 17, 2019
Research and Development Genentech, Roche, gcprs, pharma, sosei

Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …

News
roche

Roche unveils wave of strong Hemlibra data in haemophilia A with or without factor VIII inhibitors

July 9, 2019
Manufacturing and Production, Research and Development Roche, haemophilia, pharma

Roche revealed a swathe of new data on Hemlibra (emicizumab) at the International Society on Thrombosis and Haemostasis (ISTH) 2019 …

News

Roche’s Xofluza proves non-inferior to Tamiflu in children with flu

July 3, 2019
Research and Development Roche, Tamiflu, flu, pharma

Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …

News

Roche’s Tecentriq scores CHMP recommendation in PD-L1+ metastatic triple-negative breast cancer

July 2, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Roche, breast cancer, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atezolizumab) has been recommended by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in combination …

News

Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours

June 18, 2019
Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma

Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …

News

Roche scores FDA approval for Polivy combo in diffuse large B-cell lymphoma

June 11, 2019
Manufacturing and Production, Sales and Marketing Polivy, Roche, lymphoma, pharma

Roche is celebrating the decision taken by the FDA to approve its anti-CD79b antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) in combination …

News
roche__tree

Phase 1/2 data show Roche’s entrectinib shrinks tumours with NTRK, ROS1 or ALK gene fusions in children & adolescents

May 17, 2019
Medical Communications, Research and Development Cancer, Roche, entrectinib, pharma

Roche has unveiled new Phase 1/2 data for its selective tyrosine kinase inhibitor entrectinib, demonstrating its ability to shrink recurrent …

News

FDA greenlights Roche and AbbVie’s Venclexta for chronic lymphocytic leukaemia

May 16, 2019
Sales and Marketing AbbVie, Cancer, FDA, Roche, Venclexta, leukaemia, pharma

Venclexta (venetoclax), the oral B-cell lymphoma-2 (BCL-2) inhibitor co-developed by AbbVie and Roche, has been approved by the FDA in …

News
roche__tree

Roche’s Tecentriq combo shows promise in first-line triple-negative breast cancer

April 1, 2019
Research and Development, Sales and Marketing Cancer, Roche, breast cancer, pharma, tecentriq

Roche has revealed new Phase 1b data on a new Tecentriq combo, showing early promise in the first-line treatment of …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Biogen, Eisai, FDA, Merck, NICE, Pfizer, Roche, Sandoz

This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on …

News

Roche’s Tecentriq chalks up another FDA approval, this time in first-line extensive-stage small cell lung cancer

March 20, 2019
Research and Development, Sales and Marketing FDA, Roche, lung cancer, pharma, tecentriq

Roche has secured another US approval for its immunotherapy Tecentriq (atezolizumab), as the FDA reveals its approval of the drug …

News
roche_dark_0

FDA puts multiple myeloma trial on hold after patient deaths

March 20, 2019
Research and Development AbbVie, FDA, Roche, clinical trials, multiple myeloma

The FDA has placed a partial clinical hold on studies of multiple myeloma treatment Venclexta/Venclyxto (venetoclax) following a number of …

News
images

Roche scores two EU approvals in haemophilia and rare autoimmune disease

March 15, 2019
Medical Communications EC, EU, Europe, Roche, haemophilia, rare diseases

The European Commission (EC) has approved Roche’s haemophilia treatment Hemlibra (emicizumab). The approval comes as the EC approved Roche’s MabThera …

News
roche_dark_0

Roche and Chugai’s Hemlibra scoops up EU approval in the prevention of severe haemophilia A without factor VIII inhibitors

March 14, 2019
Sales and Marketing Chugai, Hemlibra, Roche, haemophilia, pharma

Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023